Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”
The group was recently asked to provide input on a new set of recommendations for image-guided biopsies of suspicious breast lesions—offering providers clarity on key clinical scenarios.
Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease.
In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.
A study presented at the annual meeting of the Radiological Society of North America is raising questions about the safety of consuming even the slightest amount of alcohol while pregnant.
Although the Affordable Care Act eliminated OOP costs for screening mammograms under most insurance plans, that coverage does not carry over to the additional exams that are needed when abnormal findings are uncovered.
A patient survey revealed that more than one in five women would likely skip indicated follow-up screenings if they had to pay a deductible, even if an initial mammogram revealed abnormalities.
When it comes to breast imaging, a few new technologies have improved the visualization of lesions and diagnostic procedures. But a new modality could change the game completely.
JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.
These appearances are important to recognize because, although cancer detection rates are similar among both races, mortality is approximately 40% higher among African American women in comparison to Non-Latina white women.